1988
DOI: 10.7164/antibiotics.41.1515
|View full text |Cite
|
Sign up to set email alerts
|

Pyrindamycins A and B, new antitumor antibiotics.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

1
17
0

Year Published

1989
1989
2019
2019

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(18 citation statements)
references
References 5 publications
1
17
0
Order By: Relevance
“…6,7 The present work thus demonstrates the first synthesis of racemic SF-2322 (3) by a short and efficient route. Extension of this work including applications of these findings in synthesizing optically active SF-2322 is in progress.…”
mentioning
confidence: 88%
See 2 more Smart Citations
“…6,7 The present work thus demonstrates the first synthesis of racemic SF-2322 (3) by a short and efficient route. Extension of this work including applications of these findings in synthesizing optically active SF-2322 is in progress.…”
mentioning
confidence: 88%
“…4,5 Meanwhile, SF-2312 (3), a phosphonic acid antibiotic active against Gram-positive and Gram-negative bacteria, was isolated from Micromonospora sp. 6,7 Despite its unique structure in having a 1,5-dihydroxy-2-pyrrrolidone ring, attempts at preparation of 3 and the assignment of the stereochemistry have not been made so far. We describe herein the first, efficient synthesis of racemic SF-2312 (3) as a preliminary study for asymmetric synthesis of 3.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Ohba et al 5) have reported pyrindamycins A and B which are identical to duocarmycins C2 and Cl, respectively. The structures of duocarmycins were revealed by spectroscopic and chemical analysis6) (Fig.…”
mentioning
confidence: 99%
“…The molecular formula of duocarmycin The LD50 value of duocarmycin Bx (4) is 0.37 mg/kg (iv) in mice and that of duocarmycin B2 (5) is 0.28 mg/kg (iv). Duocarmycins B± (4) and B2 (5) are more potent than duocarmycins Qand C2. The antitumor activity of duocarmycins against mouse sarcoma 180 is summarized in Table 3.…”
mentioning
confidence: 99%